At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Colonization, Safety, Tolerance, and Effects of Three Probiotic Strains on the Immune System of Healthy Adults
In Brief
A clinical study evaluating Probiotic CNCM I-4034, Probiotic CNCM I-4035, and 3 other interventions for Conditions Influencing Health Status. Completed, enrolled 103 participants across 4 sites.
Detailed Summary
The present report describes the design of a clinical trial performed on healthy adult individuals to check whether the daily intake of the new Hero strains contribute to intestinal colonization, under safe and tolerable conditions, with a positive contribution to health and wellbeing of healthy individuals. Daily intake of one or several probiotic strains, (CNCM I-4034, CNCM I-4035, CNCM I-4036), increases intestinal microbiota in healthy adults, being safe and well tolerated. The regular intake has positive effects on the gastrointestinal and immune system.
Study Details
Timeline
Interventions
Probiotic CNCM I-4034 in a concentration of 9x10E9 cfu (colony forming unit) per day during 28 days.
9x10E9 cfu (colony forming unit) per day during 28 days.
9x10E9 cfu (colony forming unit) per day during 28 days.
9x10E9 cfu (colony forming unit) per day during 28 days.
Placebo capsule for 28 days.